{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:15:42Z","timestamp":1792289742907,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd010052","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,8,31]],"date-time":"2014-08-31T00:00:00Z","timestamp":1409443200000}}],"reference-count":40,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010052.pub2","type":"journal-article","created":{"date-parts":[[2014,8,31]],"date-time":"2014-08-31T18:04:24Z","timestamp":1409508264000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Time course for blood pressure lowering of dihydropyridine calcium channel blockers"],"prefix":"10.1002","volume":"2014","author":[{"given":"Niousha","family":"Ghamami","sequence":"first","affiliation":[{"name":"McMaster University; Biology and Pharmacology; 1280 Main Street West Hamilton ON Canada L8S 4L8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy Hsiang Yu","family":"Chiang","sequence":"additional","affiliation":[{"name":"University of British Columbia; Department of Anesthesiology, Pharmacology and Therapeutics; Vancouver BC Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Dormuth","sequence":"additional","affiliation":[{"name":"University of British Columbia; Department of Anesthesiology, Pharmacology and Therapeutics; 210 - 1110 Government St Victoria BC Canada V8W 1Y2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M","family":"Wright","sequence":"additional","affiliation":[{"name":"University of British Columbia; Department of Anesthesiology, Pharmacology and Therapeutics; Vancouver BC Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,8,31]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD010052.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/00005344-199212000-00002","article-title":"Arterial and antihypertensive effects of nitrendipine: a double-blind comparison versus placebo","volume":"20","author":"Asmar","year":"1992","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD010052.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00004872-198710000-00015","article-title":"Evaluation of slow release nicardipine in essential hypertension by casual and ambulatory blood pressure measurements. Effects of acute versus chronic administration","volume":"5","author":"Bellet","year":"1987","journal-title":"Journal of Hypertension"},{"issue":"6","key":"10.1002\/14651858.CD010052.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.jhh.1001577","article-title":"Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension","volume":"17","author":"Chrysant","year":"2003","journal-title":"Journal of Human Hypertension"},{"issue":"3","key":"10.1002\/14651858.CD010052.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/01.mbp.0000209087.40117.b3","article-title":"Use of 24-h ambulatory blood pressure monitoring to assess blood pressure control: a comparison of olmesartan medoxomil and amlodipine besylate","volume":"11","author":"Chrysant","year":"2006","journal-title":"Blood Press Monitoring"},{"issue":"2","key":"10.1002\/14651858.CD010052.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1378\/chest.104.2.427","article-title":"Sustained-release nicardipine in mild-to-moderate hypertension","volume":"104","author":"Fagan","year":"1993","journal-title":"Chest"},{"key":"10.1002\/14651858.CD010052.pub2-BIB0006|cit6","first-page":"16","article-title":"Evaluation by 24-hour ambulatory blood pressure monitoring of efficacy of manidipine hydrochloride 10, 20 or 40 mg once daily as compared to placebo in treating mild to moderate essential hypertension: a double-blind, randomized, parallel group, placebo-controlled study","volume":"5","author":"Fogari","year":"1996","journal-title":"Blood Pressure. Supplement"},{"issue":"3","key":"10.1002\/14651858.CD010052.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1023\/A:1007700326811","article-title":"Effect of low-dose manidipine on ambulatory blood pressure in very elderly hypertensives","volume":"13","author":"Fogari","year":"1999","journal-title":"Cardiovascular Drugs and Therapy"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD010052.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0895-7061(01)02224-5","article-title":"Amlodipine versus chlorthalidone versus placebo in the treatment of stage I isolated systolic hypertension","volume":"15","author":"Grimm","year":"2002","journal-title":"American Journal of Hypertension"},{"issue":"6","key":"10.1002\/14651858.CD010052.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0149-2918(96)80076-2","article-title":"Treatment of patients with essential hypertension: amlodipine 5 mg\/benazepril 20 mg compared with amlodipine 5 mg, benazepril 20 mg, and placebo","volume":"18","author":"Kuschnir","year":"1996","journal-title":"Clinical Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD010052.pub2-BIB0010|cit10","first-page":"295","article-title":"A comparison of the efficacies and duration of action of the angiotensin II receptor blockers telmisartan and amlodipine","volume":"3","author":"Lacourciere","year":"1998","journal-title":"Blood Pressure Monitoring"},{"issue":"3","key":"10.1002\/14651858.CD010052.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"39A","DOI":"10.1016\/0002-9149(94)90273-9","article-title":"The effect of amlodipine on ambulatory blood pressure in hypertensive patients","volume":"73","author":"Burris","year":"1994","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD010052.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1097\/00005344-198812007-00018","article-title":"A double-blind evaluation of the effect of amlodipine on ambulatory blood pressure in hypertensive patients","volume":"12 Suppl 7","author":"Mroczek","year":"1988","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1002\/14651858.CD010052.pub2-BIB0013|cit13","first-page":"S24","article-title":"A double-blind evaluation of the effect of amlodipine on ambulatory blood pressure","volume":"67 Suppl 5","author":"Mroczek","year":"1991","journal-title":"Postgraduate Medical Journal"},{"issue":"12 Pt 1","key":"10.1002\/14651858.CD010052.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1097\/00004872-199816120-00017","article-title":"Antihypertensive efficacy of lercanidipine at 2.5, 5 and 10 mg in mild to moderate essential hypertensives assessed by clinic and ambulatory blood pressure measurements. Multicenter Study Investigators","volume":"16","author":"Omboni","year":"1998","journal-title":"Journal of Hypertension"},{"issue":"5","key":"10.1002\/14651858.CD010052.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/ageing\/28.5.451","article-title":"Amlodipine lowers blood pressure without affecting cerebral blood flow as measured by single photon emission computed tomography in elderly hypertensive subjects","volume":"28","author":"Pandita-Gunawardena","year":"1999","journal-title":"Age and Ageing"},{"issue":"10","key":"10.1002\/14651858.CD010052.pub2-BIB0016|cit16","first-page":"921","article-title":"Efficacy of a low dose nifedipine GITS (20 mg) in patients with mild to moderate hypertension","volume":"13","author":"Toal","year":"1997","journal-title":"Canadian Journal of Cardiology"},{"issue":"9","key":"10.1002\/14651858.CD010052.pub2-BIB0017|cit17","first-page":"613","article-title":"Low dosages of felodipine ER once daily as monotherapy in elderly hypertensive patients: effect on ambulatory blood pressure and quality of life","volume":"10","author":"Ree","year":"1996","journal-title":"Journal of Human Hypertension"},{"issue":"4","key":"10.1002\/14651858.CD010052.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/MBP.0b013e32833c5722","article-title":"Effects of telmisartan and amlodipine in combination on ambulatory blood pressure in stages 1-2 hypertension","volume":"15","author":"White","year":"2010","journal-title":"Blood Pressure Monitoring"},{"key":"10.1002\/14651858.CD010052.pub2-BIB0020|cit19","first-page":"23-30; discussi","article-title":"The 24-hour efficacy of a new once-daily formulation of nifedipine. Italian Nifedipine GITS Study Group","volume":"48 Suppl 1","author":"Zanchetti","year":"1994","journal-title":"Drugs"},{"issue":"5","key":"10.1002\/14651858.CD010052.pub2-BIB0021|cit20","first-page":"S23","article-title":"Trough and peak effects of a single daily dose of nifedipine gastrointestinal therapeutic system (GITS) as assessed by ambulatory blood pressure monitoring. Italian Nifedipine GITS Study Group","volume":"12","author":"Zanchetti","year":"1994","journal-title":"Journal of Hypertension Supplement"},{"issue":"5","key":"10.1002\/14651858.CD010052.pub2-BIB0019|cit21","first-page":"S334","article-title":"Antihypertensive effects of nifedipine gastrointestinal therapeutic system on clinic and ambulatory blood pressure in essential hypertensives. Italian GITS Study Group","volume":"11","author":"Zanchetti","year":"1993","journal-title":"Journal of Hypertension Supplement"},{"issue":"13","key":"10.1002\/14651858.CD010052.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"28E","DOI":"10.1016\/0002-9149(92)90015-Q","article-title":"Effectiveness of once-daily monotherapy with a new nifedipine sustained release calcium antagonist","volume":"69","author":"Carr","year":"1992","journal-title":"American Journal of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD010052.pub2-BIB0023|cit23","first-page":"932","article-title":"Double-blind placebo-controlled study of the antihypertensive efficacy of nitrendipine in patients submitted to ambulatory blood pressure monitoring","volume":"46","author":"Honorato","year":"1989","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"key":"10.1002\/14651858.CD010052.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/00005344-199106183-00005","article-title":"The antihypertensive action of isradipine in mild essential hypertension","volume":"18 Suppl 3","author":"Viskoper","year":"1991","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"11","key":"10.1002\/14651858.CD010052.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/j.1552-4604.1990.tb03588.x","article-title":"Antihypertensive effects of a new sustained-release formulation of nifedipine","volume":"30","author":"Zachariah","year":"1990","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD010052.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","author":"The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group","year":"2002","journal-title":"JAMA"},{"issue":"11","key":"10.1002\/14651858.CD010052.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1524-6175.2004.03683.x","article-title":"The role of existing and newer calcium channel blockers in the treatment of hypertension","volume":"6","author":"Basile","year":"2004","journal-title":"Journal of Clinical Hypertension (Greenwich)"},{"issue":"8","key":"10.1002\/14651858.CD010052.pub2-BIB0028|cit28","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003654","article-title":"Calcium channel blockers versus other classes of drugs for hypertension","author":"Chen","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2 Pt 2","key":"10.1002\/14651858.CD010052.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"43S","DOI":"10.1016\/S0895-7061(98)00279-9","article-title":"Circadian variation in blood pressure: implications for the elderly patient","volume":"12","author":"Elliott","year":"1999","journal-title":"American Journal of Hypertension"},{"issue":"9","key":"10.1002\/14651858.CD010052.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1751-7176.2011.00513.x","article-title":"Calcium channel blockers","volume":"13","author":"Elliott","year":"2011","journal-title":"Journal of Clinical Hypertension (Greenwich)"},{"key":"10.1002\/14651858.CD010052.pub2-BIB0031|cit31","unstructured":"Higgins JPT Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD010052.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1081\/CEH-120028556","article-title":"Risers and extreme-dippers of nocturnal blood pressure in hypertension: antihypertensive strategy for nocturnal blood pressure","volume":"26","author":"Kario","year":"2004","journal-title":"Clinical and Experimental Hypertension"},{"issue":"2","key":"10.1002\/14651858.CD010052.pub2-BIB0033|cit33","first-page":"e92","article-title":"Failure of psychological interventions to lower blood pressure: a randomized controlled trial","volume":"3","author":"Perez","year":"2009","journal-title":"Open Medicine"},{"key":"10.1002\/14651858.CD010052.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1001\/jama.289.19.2534","article-title":"Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis","volume":"289","author":"Psaty","year":"2003","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD010052.pub2-BIB0035|cit35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007436","article-title":"Time course for blood pressure lowering of thiazides","author":"Sekhon","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD010052.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1524-6175.2005.04140.x","article-title":"Pharmacotherapy review: calcium channel blockers","volume":"8","author":"Sica","year":"2006","journal-title":"Journal of Clinical Hypertension (Greenwich)"},{"key":"10.1002\/14651858.CD010052.pub2-BIB0037|cit37","unstructured":"Sterne JAC Egger M Moher D Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"4","key":"10.1002\/14651858.CD010052.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3109\/08037059609079672","article-title":"Third generation calcium entry blockers","volume":"5","author":"Toyo-Oka","year":"1996","journal-title":"Blood Pressure"},{"issue":"9359","key":"10.1002\/14651858.CD010052.pub2-BIB0039|cit39","first-page":"1527","article-title":"Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials","volume":"362","author":"Turnbull","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD010052.pub2-BIB0040|cit40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001841","article-title":"First-line drugs for hypertension","author":"Wright","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD010052.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T18:12:12Z","timestamp":1720289532000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010052.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Hypertension Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,8,31]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010052.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,31]]}}}